PSMA is a cell surface receptor, which is increased in all stages and grades of PCa and routinely used as a diagnostic and therapeutic target in the clinic [38,39,40,41,42], which is, however, also heterogeneously expressed among PCa cells [43]. Here, CD177 is linked to posterior cortical atrophy.